financetom
Business
financetom
/
Business
/
US Bancorp Tops Second-Quarter Profit Views, Sees Full-Year Revenue Growth at Low End
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Bancorp Tops Second-Quarter Profit Views, Sees Full-Year Revenue Growth at Low End
Jul 17, 2025 8:22 AM

11:12 AM EDT, 07/17/2025 (MT Newswires) -- US Bancorp ( USB ) reported higher-than-expected second-quarter earnings on Thursday as revenue rose year on year, while the lender now sees full-year revenue growth at the low end of its guidance.

Per-share earnings rose to $1.11 for the June quarter from $0.97 a year earlier and surpassed the FactSet-polled consensus of $1.07. Net revenue grew 2% year on year to $7 billion.

Net interest income increased to $4.08 billion on taxable-equivalent basis from $4.05 billion in the year-earlier quarter. Noninterest income gained 3.9%.

For 2025, the bank expects adjusted revenue growth to be at the lower end of the previously-disclosed guidance of 3% to 5%, Chief Financial Officer John Stern said at an earnings call, according to a FactSet transcript.

Net interest margin eased to to 2.66% in the second quarter from 2.67% a year ago, below the 2.72% consensus view. Net interest margin fell six basis points sequentially.

US Bancorp's ( USB ) shares were down 2.2% intraday, taking its year-to-date decline to 6.6%.

For the third quarter, the bank anticipates net interest income of $4.1 billion to $4.2 billion on a fully taxable-equivalent basis, Stern told analysts.

Price: 44.61, Change: -1.07, Percent Change: -2.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump administration plans new probe into global drug pricing, FT reports
Trump administration plans new probe into global drug pricing, FT reports
Oct 21, 2025
(Reuters) -President Donald Trump's administration is preparing a new probe into drug pricing practices among U.S. trading partners, a move that would lay the ground for fresh tariffs, the Financial Times reported on Wednesday, citing sources familiar with the matter.  Reuters could not immediately verify the report.  The imminent investigation would consider whether U.S. trading partners are underpaying for drugs,...
Russia's Orenburg plant restarts taking gas from Kazakhstan field, energy minister says
Russia's Orenburg plant restarts taking gas from Kazakhstan field, energy minister says
Oct 21, 2025
Oct 22 (Reuters) - Russia's Orenburg gas plant has restarted receiving natural gas from Kazakhstan's Karachaganak field, Kazakhstan's energy minister said on Wednesday. ...
Ukraine's Zelenskiy to visit Sweden on Wednesday for defence talks
Ukraine's Zelenskiy to visit Sweden on Wednesday for defence talks
Oct 21, 2025
STOCKHOLM, Oct 22 (Reuters) - Ukrainian President Volodymyr Zelenskiy will visit Sweden on Wednesday to meet with Prime Minister Ulf Kristersson in the city of Linkoping where the two leaders visit a company, the Swedish government said in a statement. The prime minister and President Zelenskiy will hold a joint press conference to present news regarding ​​defence exports, the Swedish...
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
Oct 21, 2025
Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a new standard of care in combination in first line unfit acute myeloid leukemia, an aggressive blood cancer affecting older adults Ipsen to acquire all issued and outstanding shares of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved